CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosisTing Zhang, Rui‐Ping Xiao, Xinli Hu et al.|Nature Medicine|2016Cited by 791
CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repairMao Zhang, Rui‐Ping Xiao, Hua Gao et al.|Nature Cell Biology|2019Cited by 74
Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyondJunxia Zhang, Yan Zhang, Dairu Liu et al.|British Journal of Pharmacology|2018Cited by 64
CaMKII-δ9 Induces Cardiomyocyte Death to Promote Cardiomyopathy and Heart FailureMao Zhang, Yan Zhang, Junxia Zhang et al.|Frontiers in Cardiovascular Medicine|2022Cited by 8
Danhong Injection targets CaMKII through Dihydrotanshinone I to alleviate cardiomyocyte death and inflammation in viral myocarditisJunxia Zhang, Yan Zhang, Chengcheng Zhao et al.|Science China Life Sciences|2025Cited by 2